Meeting on draft pharma policy called in New Delhi on Aug 30 with stakeholders
A day-long meet on draft pharmaceutical policy
is called by department of pharmaceuticals (DoP) on August 30 in New Delhi to
discuss key aspects of the policy with representative bodies of pharmaceutical
industry and trade.
Representatives from IPA, IDMA, BDMA, FOPE,
OPPI, CIPI, FICCI, ASSOCHAM, CII, PHD, Pharmexcil, AIDAN, Nathealth, Prayas,
Consumer Connexion, LOCOST, JSA, AIOCD, AICDF, Consumer India have been invited
for the conference.
The inaugural session of the meet will be addressed by Sudhansh Pant,
joint secretary of DoP, Jai Priye Prakash, secretary of DoP, CK Mishra,
secretary of ministry of health and family welfare, Ramesh Abhishek, secretary
of department of industrial policy and promotion, Rita Teaotia, secretary,
department of commerce, Ajay Narayan Jha, secretary, ministry of environment,
forests and climate change, Bhpendra Singh, chairman of National Pharmaceutical
Pricing Authority, Rajneesh Tingal, joint secretary of DoP.
Divided into four sessions, the symposium will
feature eight roundtable discussions on varied issues pertaining to
pharmaceutical sector. The first session will have roundtable discussion on
“Understanding and analyzing the extent of India's dependence on imports for
key APIs (especially from China) followed by another roundtable discussion on
“environmental issue”.
The second session will also have two
roundtable discussions on “Quality standards for exports of pharmaceutical
products” and “R&D, drug discovery and innovation of new molecules”
followed by roundtable discussions on “Contract/loan licensing manufacturing”
and “Promotion of generic formulations” in third session. The fourth session
will witness roundtable discussions on two contentious issues in pharma segment
such as “Intellectual property rights issues” and “Pricing aspects including
functioning of NPPA”.
Comments
Post a Comment